Clinical Trials Directory

Trials / Completed

CompletedNCT04733846

Treatment of Corneal Wounds Emergencies During the COVID-19 Shutdown: Absorbable 10-0 Vicryl Sutures as a Valuable Strategy.

Status
Completed
Phase
Study type
Observational
Enrollment
10 (actual)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Vicryl (polyglactin) 10-0 resorbable suture is rarely used, little known to ophthalmologists but may offer therapeutic and practical advantages in eligible cases of corneal trauma, particularly during a COVID-19 pandemic. This has imposed new sanitary restrictions : limited access to the operating room in ophthalmology only for functional emergencies and a drastically reduced capacity for external consultations in favor of teleconsultation. The aim of this study is to evaluate the Vicryl 10-0 (polyglactin 910) resorbable monofilament suture in corneal trauma, rather than classic Nylon 10-0: structural and functional results, and adaptation of postoperative follow-up during a sanitary crisis period.

Conditions

Interventions

TypeNameDescription
OTHERdata collectionCollection of clinical and paraclinical data during preoperative consultation Collection of clinical and paraclinical data during post-operative consultations Tele-consultation to determine if criteria for good healing / adherence, treatment tolerance / response to questions Remote follow-up 6 and 12 months after the trauma

Timeline

Start date
2020-03-18
Primary completion
2020-12-05
Completion
2021-12-05
First posted
2021-02-02
Last updated
2022-03-29

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04733846. Inclusion in this directory is not an endorsement.

Treatment of Corneal Wounds Emergencies During the COVID-19 Shutdown: Absorbable 10-0 Vicryl Sutures as a Valuable Strat (NCT04733846) · Clinical Trials Directory